What AFC Agro Biotech does

AFC Agro Biotech Ltd. is a Bangladeshi public biotechnology company headquartered in Dhaka that manufactures biologically oriented pharmaceutical inputs—specifically key raw materials for antibiotics, proteins, and enzymes—through fermentation processes using locally sourced agro-based substrates such as corn starch, potato starch, and molasses. The company positions itself as the first-of-its-kind agro-based pharmaceutical fermentation facility in Bangladesh, with capabilities spanning strain development through large-scale manufacturing, supported by Class-A certified operations and a stated culture of continuous improvement and pollution prevention.

The company's product surface targets three downstream verticals: the pharmaceutical industry (primary, supplying API/intermediate inputs), the food industry, and the textile industry. Its stated value proposition centers on import substitution—reducing Bangladesh's foreign currency expenditure by replacing imported fermentation-derived raw materials with domestically manufactured equivalents—and on creating white-collar biotechnology employment. The technology differentiator is the use of agro-based, locally available raw materials in pharmaceutical-grade fermentation rather than imported feedstocks.

Commercially, AFC Agro Biotech operates as a B2B industrial input supplier, listed on the Dhaka Stock Exchange under ticker AFCAGRO, with 11-50 employees and a single Dhaka production facility (Tanaka Tower, Segun Bagicha). The board comprises political, industrial, financial, and scientific figures, with directorships overlapping across the AFC group of companies (Active Fine Chemicals, AFC Health, AFC Capital). Pricing is not publicly disclosed; no named customers, contract structures, or segment-level revenue splits are available. The company has no disclosed AI/ML capabilities, and its competitive moat rests on first-mover local fermentation status, proprietary process know-how, and an interlocking group ecosystem rather than software or data advantages.

Name

AFC Agro Biotech

Legal name

AFC Agro Biotech Ltd.

Website

https://afcagrobiotech.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

AFC Agro Biotech Ltd. is a Dhaka-based, DSE-listed biotech that manufactures fermentation-derived raw materials for antibiotics, proteins, and enzymes from local agro-based substrates (corn starch, potato starch, molasses) for Bangladesh's pharmaceutical, food, and textile sectors.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Manufacturing

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Other Basic Organic Chemical Manufacturing (32519)

SIC

Biological Products, (No Disgnostic Substances) (2836), Industrial Organic Chemicals (2860)

akta.pro primary industry

Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB)

akta.pro secondary industries

Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE)

Keywords

• Pharmaceutical fermentation
• Antibiotic raw materials
• Enzyme manufacturing
• Biotech manufacturing
• Agro-based pharmaceuticals

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D

Core offering

AFC Agro Biotech Ltd manufactures biologically oriented pharmaceutical products — specifically key raw materials of antibiotics, proteins, and enzymes — using locally available agro-based raw materials such as corn starch, potato starch, and molasses. The company operates the first agro-based pharmaceutical fermentation facility of its kind in Bangladesh, covering the full spectrum from strain development through large-scale manufacturing for downstream pharmaceutical, food, and textile sector customers.

Product overview

AFC Agro Biotech Ltd is a Bangladeshi biotechnology company focused on manufacturing biologically-oriented pharmaceutical products including key raw materials for antibiotics, proteins, and enzymes from locally available agro-based raw materials such as corn starch, potato starch, and molasses. The company operates as a first-of-its-kind facility in Bangladesh, covering the full spectrum from strain development through large-scale manufacturing of pharmaceutical fermentation products. AFC Agro Biotech positions itself as an industry leader in agro-based pharmaceutical fermentation, offering Class-A certified operations with high quality and compliance standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibiotic Raw Materials Key raw materials for antibiotics produced via agro-based pharmaceutical fermentation from locally available inputs (corn starch, potato starch, molasses), supplied to pharmaceutical manufacturers in Bangladesh as an import-substitution input.
• Proteins (Fermentation-Derived) Fermentation-derived protein products manufactured from agro-based raw materials for pharmaceutical, food, and textile industry customers.
• Enzymes (Fermentation-Derived) Fermentation-derived enzyme products manufactured from agro-based raw materials, used as inputs by pharmaceutical, food processing, and textile manufacturers.
• Pharmaceutical Fermentation Products (Agro-Based) Broader category of biologically oriented pharmaceutical fermentation products manufactured from locally available agro-based raw materials (corn starch, potato starch, molasses), offered to pharmaceutical, food, and textile sector buyers.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Laurus Labs Limited: India-based API and intermediates manufacturer with significant fermentation capability; comparable business model focused on supplying APIs/intermediates to global generic-pharma customers from a South Asian cost base.
• Aurobindo Pharma Limited: India-headquartered global generic manufacturer with large fermentation-based API capacity; the most relevant international operational peer and benchmark for cost-competitive API production from a South Asian base.
• Active Fine Chemicals Limited: Bangladesh-based sister company producing APIs and fine chemicals via fermentation and chemical synthesis; same founders/directors and overlapping product portfolio make it the closest operational peer and most direct comparator for AFC Agro Biotech.

Broad incumbents

• ACI Limited: Bangladesh conglomerate with significant pharmaceutical and consumer health divisions; competes for pharma market share in Bangladesh and is a potential large-volume customer for locally manufactured API inputs.
• DSM-Firmenich: Global fermentation giant producing vitamins, enzymes, and bioproducts at industrial scale; represents the upper-bound incumbent in the fermentation/biocatalysis space where AFC Agro Biotech operates.
• Beximco Pharmaceuticals Limited: Major Bangladeshi generic-pharma manufacturer and exporter; represents the captive domestic demand for fermentation-derived APIs/intermediates that AFC Agro Biotech is positioning to supply locally.
• Novozymes A/S: Global leader in industrial enzymes and microbial fermentation; benchmark for AFC Agro Biotech's enzyme production ambitions and indicative of the scale, R&D, and capital intensity required to compete in industrial biotechnology.
• Square Pharmaceuticals Limited: Largest pharmaceutical manufacturer in Bangladesh; a downstream customer for AFC's API/intermediate products and the dominant domestic incumbent shaping the local pharmaceutical supply chain AFC Agro Biotech serves.

Regional players

• Renata Limited: Bangladesh-based pharmaceutical manufacturer with strong domestic market position; regional pharma peer that shares AFC Agro Biotech's Bangladesh-centric customer base and faces the same import-substitution dynamics.
• Incepta Pharmaceuticals Limited: Bangladesh-based generic-pharma manufacturer with large domestic and export operations; comparable regional pharma customer and a logical downstream buyer of AFC's fermentation-derived APIs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/afc-agro-biotech

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AFC Agro Biotech